CH5183284 clinical trials
Also written Debio 1347.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses CH5183284 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Debiopharm International SA (2) · Memorial Sloan Kettering Cancer Center (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses CH5183284 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)TerminatedPhase 2Debiopharm International SANCT03834220Written as Debio 1347How we know
- A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast CancerCompletedPhase 1/2Memorial Sloan Kettering Cancer CenterNCT03344536Written as Debio 1347How we know
- Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) AlterationsTerminatedPhase 1Debiopharm International SANCT01948297Written as Debio1347 (CH5183284)How we know